AI assistant
Sending…
Medtronic plc — Director's Dealing 2022
Dec 9, 2022
29841_dirs_2022-12-09_3b5cb682-51f2-4787-a2ea-0cc3e9fd9838.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Medtronic plc (MDT)
CIK: 0001613103
Period of Report: 2022-12-07
Reporting Person: Salmon Sean (EVP & President Cardiovascular)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-12-07 | Ordinary Shares | F | 300 | $79.04 | Disposed | 36088 | Direct |
Footnotes
F1: This balance increased by 174 shares due to exempt acquisitions through dividend reinvestment.
F2: The reported transaction involved the withholding of 300 shares of stock issuable upon the early vesting of an equal number of restricted stock units to pay taxes associated with the reporting person becoming retirement eligible.
More from Medtronic plc
Regulatory Filings
2026
May 18
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 24
Interim / Quarterly Report
2026
Feb 24
Regulatory Filings
2026
Feb 17
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Jan 29
Major Shareholding Notification
2026
Jan 29
Director's Dealing
2025
Dec 17